EP4262743A1 - Extrait de dendrobium fimbriatum et composition cosmétique non rincée en comprenant - Google Patents

Extrait de dendrobium fimbriatum et composition cosmétique non rincée en comprenant

Info

Publication number
EP4262743A1
EP4262743A1 EP21848276.8A EP21848276A EP4262743A1 EP 4262743 A1 EP4262743 A1 EP 4262743A1 EP 21848276 A EP21848276 A EP 21848276A EP 4262743 A1 EP4262743 A1 EP 4262743A1
Authority
EP
European Patent Office
Prior art keywords
extract
dendrobium fimbriatum
skin
cosmetic
dendrobium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP21848276.8A
Other languages
German (de)
English (en)
French (fr)
Inventor
Lorène GOURGUILLON
Catherine HEUSEULE
Anne-Laure Bulteau
Lauren SOBILO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LVMH Recherche GIE
Original Assignee
LVMH Recherche GIE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LVMH Recherche GIE filed Critical LVMH Recherche GIE
Publication of EP4262743A1 publication Critical patent/EP4262743A1/fr
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/898Orchidaceae (Orchid family)
    • A61K36/8984Dendrobium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/15Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/53Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization

Definitions

  • TITLE Dendrobium fimbriatum extract and leave-on cosmetic composition comprising
  • the present invention relates to the field of cosmetics. It relates in particular to a leave-in cosmetic composition comprising an orchid extract of the species Dendrobium fimbriatum, as well as its use for preventing and/or reducing the signs of skin ageing. It also relates to a particular extract of Dendrobium fimbriatum and to an extraction process for obtaining such an extract.
  • the skin is the body's first protective barrier against the environment. It is therefore subject to many factors likely to induce signs of skin aging, whether of exogenous origin (eg: UV radiation, temperature variations, atmospheric pollution, cigarette smoke, etc.) or endogenous (eg : hormone). We will talk about extrinsic aging and intrinsic (or physiological) aging, respectively.
  • exogenous origin eg: UV radiation, temperature variations, atmospheric pollution, cigarette smoke, etc.
  • endogenous eg : hormone
  • ECM extracellular matrix
  • the ECM at the level of the dermis plays essential roles in the physiology of the skin. Its alteration will directly impact the quality of the skin, which translates essentially by a loss of firmness, elasticity as well as the appearance of fine lines or wrinkles.
  • the Applicant demonstrated in vitro the effects of an extract of Dendrobium fimbriatum on certain proteins of the dermal ECM.
  • the Dendrobium fimbriatum extract according to the invention is capable of significantly increasing the synthesis of elastin, fibrillin 1, collagen 1 and nidogen.
  • this extract also makes it possible to reduce in vitro the morphological markers of fibroblast senescence.
  • the extract of Dendrobium fimbriatum according to the invention is of cosmetic interest as an anti-ageing active ingredient, in particular for preventing and/or reducing the signs of aging such as loss of firmness, loss of elasticity, reduction the thickness of the skin, the appearance of wrinkles and/or fine lines.
  • the first object of the invention relates to a leave-in cosmetic composition for topical application to keratin materials, in particular to the skin and/or the lips and in particular the skin of the face and/or the neck, comprising an extract of Dendrobium fimbriatum.
  • leave-in cosmetic composition is understood to mean a care composition intended to remain in contact with keratin materials after application, to confer its beneficial effect (moisturizing, anti-aging, etc.), such as, for example, milks , creams, ointments, balms, sticks, gels, lotions, serums, etc. .., as opposed to “rinsed-out cosmetic compositions” intended for cleaning keratin materials (eg: shower gels, shampoos), intended to be rinsed off after application.
  • keratin materials according to the invention is understood to mean the skin and/or its appendages, and the lips. In particular, it will be the skin of the face, neck and/or body, and lips.
  • the invention also relates to the cosmetic use of an extract of Dendrobium fimbriatum, as an agent for preventing and/or reducing the signs of skin aging, in particular the loss of firmness, the loss of elasticity, the reduction in the thickness of the skin, the appearance of wrinkles and/or fine lines.
  • the invention also relates to a cosmetic process for caring for and/or making up keratin materials, in particular the skin and/or the lips, comprising the topical application to said keratin materials of a cosmetic composition according to the invention.
  • the invention also relates to an extract of Dendrobium fimbriatum, characterized in that it is obtained by an extraction process comprising at least the steps of: a) grinding the plant material; b) at least one extraction step followed by a filtration step; c) concentration of the extract obtained at the end of step b); d) addition of butylene glycol, pentylene glycol, potassium sorbate/sodium benzoate glycerol or propanediol, preferably propanediol; e) filtration, and f) obtaining an extract of Dendrobium fimbriatum.
  • the invention also relates to an extract of Dendrobium fimbriatum, characterized in that it comprises at least one metabolite chosen from betaine and cis and trans melilotoside.
  • the invention also relates to a process for obtaining an extract of Dendrobium fimbriatum comprising at least the steps of: a) grinding the plant material; b) at least one extraction step followed by a filtration step; c) concentration of the extract obtained at the end of step b); d) addition of butylene glycol, pentylene glycol, potassium sorbate/sodium benzoate, glycerol or propanediol, preferably propanediol; e) filtration, and f) obtaining an extract of Dendrobium fimbriatum.
  • Leave-in cosmetic composition comprising an extract of Dendrobium fimbriatum
  • the invention in its first aspect, relates to a leave-in cosmetic composition for topical application to keratin materials, in particular to the skin and/or the lips and in particular the skin of the face and/or the neck, comprising an extract of Dendrobium fimbriatum.
  • Dendrobium fimbriatum within the meaning of the invention is meant a plant of the family of orchids (Orchidaceae) and native to Southeast Asia. It is also known as Callista fimbriata, Dendrobium normal, Dendrobium fimbriatum var. oculatum, Dendrobium paxtonii, Callista oculata. We will speak in the rest of the description of an extract of Dendrobium fimbriatum or of Dendrobium fimbriatum var. eye.
  • the extract of Dendrobium fimbriatum is used in particular in leave-in cosmetic compositions as a cosmetic active ingredient and in particular as an “anti-aging” cosmetic active ingredient.
  • the Dendrobium fimbriatum extract according to the invention is a plant extract.
  • plant extract we generally mean an isolated substance, obtained by extraction from a plant raw material, and which does not pre-exist in nature as such.
  • plant material or “raw plant material” means all or part of the Dendrobium fimbriatum plant from which the Dendrobium fimbriatum extract according to the invention is prepared.
  • the Dendrobium fimbriatum extract according to the invention can in particular be prepared from a plant material chosen from roots, stems, flowers, petals and mixtures thereof or from the whole plant.
  • the Dendrobium fimbriatum extract according to the invention is prepared from the whole plant.
  • the plant material Prior to the extraction step itself, the plant material can be dried, freeze-dried and/or ground. Alternatively, the plant material can be used wet and then ground. According to a particular mode, the plant material is ground before extraction, for example by means of a mortar, a mixer, a traditional grinder, or any other method conventionally used in the field and known to those skilled in the art. job.
  • the extract of Dendrobium fimbriatum is a polar extract, advantageously obtained by means of a cosmetically acceptable polar solvent.
  • cosmetically acceptable is meant compatible with keratin materials, in particular the skin and/or the lips.
  • the preferred polar solvents are those consisting of a compound comprising at least one polar covalent bond of the OH type.
  • a solvent or a mixture of solvents chosen from water, C1- alcohols C4, such as ethanol, glycols, such as ethylene glycol, glycerol, butylene glycol and propylene glycol, pentylene glycol, potassium sorbate/sodium benzoate, propanediol and mixtures thereof.
  • the extract of Dendrobium fimbriatum is a hydroalcoholic extract, obtained by extraction of the plant material in a mixture of water and alcohol, the alcohol representing from 1% to 99% v/v ( volume/volume) of the water/alcohol mixture.
  • the plant material can be extracted using a mixture comprising 10% v/v water and 90% v/v alcohol; 20% v/v water and 80% v/v alcohol; 30% v/v water and 70% v/v alcohol; 40% v/v water and 60% v/v alcohol; 50% v/v water and 50% v/v alcohol; 60% v/v water and 40% v/v alcohol; 70% v/v water and 30% v/v alcohol; 80% v/v water and 20% v/v alcohol; 90% v/v water and 10% v/v alcohol.
  • the plant material is extracted using a mixture comprising 50% v/v water and 50% v/v alcohol.
  • the extract of Dendrobium fimbriatum is obtained by extraction of the plant material in a mixture of water and ethanol, in particular a mixture comprising between 45% and 55% v/v of water and between 45 and 55% v/v ethanol, preferably 50% v/v water and 55% v/v ethanol.
  • the Dendrobium fimbriatum extract according to the invention can be prepared by various extraction processes known to those skilled in the art, implementing steps of grinding the plant material, dispersing the ground material in a polar solvent, separating the soluble and insoluble phases by filtration, concentration and possible re-dissolution.
  • the extraction can be carried out hot by reflux or else by maceration at ambient temperature.
  • the extraction can also be done using well-known physicochemical techniques such as ultrasound, microwave, extrusion, pulsed electric field, subcritical water and/or cryo-extraction.
  • the extraction of the plant material is carried out hot by reflux.
  • heated is meant that the extraction temperature is at least 60° C., preferably at least 65° C., more preferably at least 70° C., preferably at least 75° C., preferably still at least 80°C.
  • the duration of the extraction may range in particular from 15 to 180 minutes, preferably from 30 to 120 minutes, preferably from 45 to 90 minutes, from 50 to 70 minutes, for example 50 , 55, 60, 65 or 70 minutes.
  • the extraction process advantageously includes a filtration step aimed at separating the liquid phase from the plant material.
  • a filtration step aimed at separating the liquid phase from the plant material.
  • suitable filtration sieves in particular with filtration diameters of 0.1 ⁇ m to 0.5 ⁇ m, in particular from 0.2 to 0.3 ⁇ m.
  • the extraction then filtration cycle can be repeated several times in order to deplete the plant material of substances with an affinity for the extraction solvent.
  • the extraction/filtration cycle can be repeated at least twice and preferably at least three times, or even four times or more, for example five times.
  • the solvent is collected and replaced by solvent not yet used in order to repeat the extraction step.
  • the successive repetition of extraction steps advantageously makes it possible to extract a maximum of compounds of interest from the plant material to be extracted, in particular by preventing the solvent from becoming saturated with molecules of interest.
  • the plant material Once the plant material has been depleted of substances with an affinity for the extraction solvent, the latter can be eliminated. Alternatively, it can be saved for other uses.
  • the extract can advantageously be concentrated by eliminating part of the extraction solvent. It is thus possible to obtain an aqueous concentrate devoid of a significant quantity of organic solvents or even, by eliminating all the extraction solvent, to obtain a dry residue.
  • the product of the extraction step can be freeze-dried or atomized to appear in the form of a powder.
  • the solvents collected at the end of each extraction/filtration cycle are combined, and the extract is concentrated under vacuum then the ethanol is then evaporated, at least partially. Finally, the concentrated extract is then diluted in propanediol then filtered before packaging.
  • suitable filtration sieves in particular with filtration diameters of 0.1 ⁇ m to 0.5 ⁇ m, in particular 0.2 ⁇ m.
  • packaging we mean the packaging of the extract obtained under conditions allowing its preservation, storage and handling.
  • the present invention therefore also relates to an extract of Dendrobium fimbriatum characterized in that it is obtained by an extraction process comprising at least the steps of: a) grinding the plant material; b) at least one extraction step followed by a filtration step; c) concentration of the extract obtained at the end of step b); d) addition of butylene glycol, pentylene glycol, potassium sorbate/sodium benzoate, glycerol or propanediol, preferably propanediol; e) filtration, and f) obtaining an extract of Dendrobium fimbriatum.
  • the extract of Dendrobium fimbriatum is obtained according to an extraction process comprising at least the following steps: a) grinding of the plant material, preferably of the whole plant, dry; b) reflux extraction using a hydroalcoholic solvent; c) filtration allowing the recovery of the marc and the extract; d) optionally, 1 to 4 repetitions of steps b) and c) from the marc collected at the end of the previous extraction/filtration step and recovery at the end of each extraction/filtration step of a new extract ; e) assembly of the extracts collected at the end of each extraction/filtration step; f) evaporation of part of the extraction solvent and concentration of the extract under vacuum; g) addition of butylene glycol, pentylene glycol, potassium sorbate/sodium benzoate, glycerol or propanediol, preferably propanediol; h) filtration, and i) packaging of the Dendrobium fimbriatum extract.
  • a mixture of water and ethanol is used as hydroalcoholic solvent, in particular a mixture comprising between 45% and 55% v/v of water and between 45 and 55% v/v of ethanol, preferably 50% v/v water and 50% v/v ethanol.
  • the extraction of the plant material by reflux is carried out hot, in particular at a temperature of at least 60° C., preferably at least 65° C., more preferably at least 70° C., preferably at least 75°C, more preferably at least 80°C.
  • the duration of the extraction for each extraction/filtration cycle is between 15 and 180 minutes, preferably between 30 and 120 minutes, preferably between 45 and 90 minutes, between 50 and 70 minutes, for example 50, 55, 60, 65 or 70 minutes.
  • the filtration steps use filtration screens with filtration diameters of 0.1 ⁇ m to 0.5 ⁇ m, in particular 0.2 to 0.3 ⁇ m.
  • the extract of Dendrobium fimbriatum is obtained according to an extraction process comprising at least the following steps: a) grinding of the dry plant, preferably of the whole plant; b) extraction under reflux with 50% ethanol at 80°C for 1 h; c) filtration allowing the recovery of marc 1 and extract X; d) extraction of marc 1 under reflux with 50% ethanol at 80° C. for 1 hour; e) filtration allowing the recovery of marc 2 and extract Y; f) extraction of marc 2 under reflux with 50% ethanol at 80° C.
  • the Dendrobium fimbriatum extract obtained according to the extraction process of the invention has the INCI name: WATER (and) PROPANEDIOL (and) DENDROBIUM FIMBRIATUM OCULATUM EXTRACT.
  • the Dendrobium fimbriatum extract according to the invention in the form of a solution, comprises approximately 1% of dry matter, approximately 35% of propanediol and approximately 64% water.
  • the percentages given are percentages by weight relative to the total weight of the extract.
  • approximately it is meant that the proportions measured can vary by +/- 10%, preferably +/- 5% and more preferably +/- 2%.
  • the extract of Dendrobium fimbriatum according to the invention in particular obtained according to the method described above, comprises a total content of minerals ranging from 300 to 1000 ppm (in particular phosphorus, magnesium, calcium, sodium and potassium), measured by the method EN ISO 17294-2 - ICP-MS.
  • ppm in particular phosphorus, magnesium, calcium, sodium and potassium
  • the Dendrobium fimbriatum extract according to the invention comprises sugars in a content ranging from 0.1% to 0.5%, measured by the anthrone method (Loewus, 1952).
  • the Dendrobium fimbriatum extract comprises polyphenols in a content ranging from 0.1% to 0.5%, measured by the Folin Ciocalteu method (Ainsworth, 2007).
  • the extract of Dendrobium fimbriatum obtained by the process described above is characterized in that it comprises at least one metabolite chosen from betaine and cis and trans melilotoside.
  • the invention therefore also relates to an extract of Dendrobium fimbriatum, characterized in that it comprises at least one metabolite chosen from betaine and cis and trans melilotoside.
  • the extract of Dendrobium fimbriatum used in the cosmetic compositions of the invention is obtained according to an extraction process as described above.
  • the extract of Dendrobium fimbriatum used in the cosmetic compositions of the invention is obtained according to an extraction process comprising at least the following steps: a) grinding of the dry plant, preferably of the whole plant; b) extraction under reflux with 50% ethanol at 80° C. for 1 h; c) filtration allowing the recovery of the marc 1 and of the extract X; d) extraction of marc 1 under reflux with 50% ethanol at 80° C. for 1 h; e) filtration allowing the recovery of the marc 2 and of the extract Y; f) extraction of marc 2 under reflux with 50% ethanol at 80° C.
  • the extract of Dendrobium fimbriatum used in the cosmetic compositions of the invention is characterized in that it comprises at least one metabolite chosen from betaine and cis and trans melilotoside, in particular betaine.
  • the invention also relates to a process for obtaining an extract of Dendrobium fimbriatum comprising at least the steps of: a) grinding the plant material; b) at least one extraction step followed by a filtration step; c) concentration of the extract obtained at the end of step b); d) addition of butylene glycol, pentylene glycol, potassium sorbate/sodium benzoate, glycerol or propanediol, preferably propanediol; e) filtration, and f) obtaining an extract of Dendrobium fimbriatum.
  • the process for obtaining an extract of Dendrobium fimbriatum comprises at least the following steps: a) grinding of the plant material, preferably of the whole plant, dry; b) reflux extraction using a hydroalcoholic solvent; c) filtration allowing the recovery of the marc and the extract; d) optionally, 1 to 4 repetitions of steps b) and c) from the marc collected at the end of the previous extraction/filtration step and recovery at the end of each extraction/filtration step of a new excerpt; e) assembly of the extracts collected at the end of each extraction/filtration step; f) evaporation of the extraction solvent and concentration of the extract under vacuum; g) addition of butylene glycol, pentylene glycol, potassium sorbate/sodium benzoate, glycerol or propanediol, preferably propanediol; h) filtration, and i) conditioning.
  • a hydroalcoholic solvent is used, a mixture of water and ethanol, in particular a mixture comprising between 45% and 55% v/v of water and between 45 and 55% v/v of ethanol, preferably 50 % v/v water and 55% v/v ethanol.
  • the extraction of the plant material by reflux is carried out hot, in particular at a temperature of at least 60° C., preferably at least 65° C., more preferably at least 70° C., preferably at least 75°C, more preferably at least 80°C.
  • the duration of the extraction for each extraction/filtration cycle is between 30 and 120 minutes, preferably between 45 and 90 minutes, between 50 and 70 minutes, such as for example 50, 55, 60, 65 or 70 minutes. .
  • the filtration steps use filtration screens with filtration diameters of 0.1 ⁇ m to 0.5 ⁇ m, in particular 0.2 ⁇ m.
  • the extract of Dendrobium fimbriatum is obtained according to an extraction process comprising at least the following steps: a) grinding of the dry plant, preferably of the whole plant; b) extraction under reflux with 50% ethanol at 80°C for 1 hour; c) filtration allowing the recovery of marc 1 and extract X; d) extraction of marc 1 under reflux with 50% ethanol at 80° C. for 1 hour; e) filtration allowing the recovery of marc 2 and extract Y; f) extraction of marc 2 under reflux with 50% ethanol at 80° C.
  • the extract of Dendrobium fimbriatum is used in cosmetic compositions in an effective amount to obtain the desired effect.
  • the extract of Dendrobium fimbriatum is present in said cosmetic composition in a content ranging from 0.01% to 10%, preferably ranging from 0.1% to 10%, in particular from 0.2% to 5%, preferably from 0.3% to 3% by weight of raw material relative to the total weight of the composition, corresponding to a content ranging from 0.0001% to 0.1%, preferably from 0.002% to 0.05%, more preferably from 0.003% to 0.03 % by weight of dry matter relative to the total weight of the composition.
  • the extract of Dendrobium fimbriatum used in the cosmetic compositions of the invention is the product marketed under the name FINGE GOLD ORCHID.
  • said cosmetic composition comprising the extract of Dendrobium fimbriatum is a composition for caring for and/or making up keratin materials, in particular the skin and/or the lips and in particular the skin of the face and/or the or neck.
  • the cosmetic composition of the invention may also comprise at least one other plant extract, such as for example an orchid extract of the species Gastrodia elata, and preferably the INCI name extract: GASTRODIA ELATA ROOT EXTRACT.
  • the extract of Gastrodia elata is present in the compositions of the invention in an effective quantity to obtain the desired effect, in particular to make it possible to prevent and/or reduce the signs of skin aging, in particular the loss of firmness, the loss elasticity, reduction in the thickness of the skin, the appearance of wrinkles and/or fine lines.
  • said extract of Gastrodia elata is present in a content ranging from 0.01% to 10%, in particular from 0.02% to 5%, preferably from 0.05% to 4% by weight of raw material ( weight of product) relative to the total weight of the composition, corresponding to a content ranging from 0.0001% to 0.1%, preferably from 0.0002% to 0.05%, more preferably from 0.0005% to 0.04% by weight of dry matter relative to the total weight of the composition.
  • the cosmetic composition of the invention comprises at least the extract of Dendrobium fimbriatum according to the invention and in addition one or more cosmetic excipients acceptable from those known to those skilled in the art with a view to obtaining a composition for topical application, for example in the form of milk, cream, ointment, water-in-oil or oil-in-water emulsion, balm, stick, gel, lotion, serum, or more powder.
  • one or more cosmetically acceptable excipients will be selected from polymers, surfactants, rheology agents, perfumes, electrolytes, pH adjusters, antioxidants, preservatives, colorants , nacres, pigments and mixtures thereof.
  • the cosmetic composition of the invention may be in any galenic form suitable for topical application to keratin materials, in particular of the skin and/or lips and in particular of the skin of the face and/or neck, comprising, in addition to the extract of Dendrobium fimbriatum according to the invention, at least one cosmetic adjuvant chosen from the group consisting of antioxidants, emollients, moisturizing agents, anti-aging agents, perfumes, and mixtures thereof.
  • the cosmetic processes and cosmetic uses described below are intended for application to keratin materials, in particular healthy keratin materials, preferably healthy skin and/or lips and in particular healthy lips (“healthy” subjects).
  • healthy keratin materials is meant keratin materials not exhibiting disorders or disorders that would be part of a pathological state (“non-healthy” subjects, suffering from a pathology). Reference will be made indiscriminately to healthy skin and/or lips or to healthy skin and/or lips in the rest of the description.
  • the extract of Dendrobium fimbriatum according to the invention is capable of significantly increasing the synthesis of several proteins of the extracellular matrix, in particular elastin, fibrillin 1, collagen 1 and the nidogen.
  • the Dendrobium fimbriatum extract according to the invention therefore has cosmetic interest, in particular as an “anti-aging” cosmetic active ingredient.
  • anti-aging cosmetic active ingredient is meant that the extract of Dendrobium fimbriatum according to the invention is effective in preventing and/or reducing the signs of skin aging, in particular loss of firmness, loss of elasticity, reduction of the thickness of the skin, the appearance of wrinkles and/or fine lines, increase cell longevity
  • the invention also relates to the cosmetic, non-therapeutic use of an extract of Dendrobium fimbriatum, as described above as an agent for preventing and/or reduce the signs of skin ageing, in particular the loss of firmness, the loss of elasticity, the reduction in the thickness of the skin, the appearance of wrinkles and/or fine lines.
  • the invention relates to the use of an extract of Dendrobium fimbriatum characterized in that it is marketed under the name FINGE GOLD ORCHID.
  • the invention relates to the use of an extract of Dendrobium fimbriatum characterized in that it is obtained by an extraction process comprising at least the steps of: a) grinding the plant material ; b) at least one extraction step followed by a filtration step; c) concentration of the extract obtained at the end of step b); d) addition of propanediol; e) filtration, and f) obtaining an extract of Dendrobium fimbriatum.
  • the invention relates to the use of an extract of Dendrobium fimbriatum characterized in that it comprises at least one metabolite chosen from cis and trans betaine and melilotoside, in particular betaine.
  • the present invention also relates to a cosmetic process for caring for and/or making up keratin materials, in particular the skin and/or the lips, comprising the topical application to said keratin materials of a cosmetic composition as described below. above.
  • the cosmetic composition used in the cosmetic uses or processes of the invention further comprises an orchid extract of the species Gastrodia elata, and preferably the extract with INCI name: GASTRODIA ELATA ROOT EXTRACT.
  • the cosmetic process is intended to prevent and/or reduce the signs of skin aging, in particular the loss of firmness, the loss of elasticity, the reduction in the thickness of the skin, the appearance of wrinkles and / or fine lines.
  • the cosmetic composition is applied to aged skin or skin showing signs of ageing.
  • the invention will now be illustrated in the following non-limiting examples.
  • the percentages (%) are expressed by weight of raw material (MP) relative to the total weight of the composition, unless otherwise indicated.
  • Step 1 grinding the whole, dry Dendrobium fimbriatum plant
  • Stage 2 extraction under reflux with 50% ethanol at 80° C. for 1 h;
  • Step 3 filtration allowing the recovery of marc 1 and extract X;
  • Step 4 extraction of marc 1 under reflux with 50% ethanol at 80°C for Ih;
  • Step 5 filtration allowing the recovery of marc 2 and extract Y;
  • Stage 6 extraction of marc 2 under reflux with 50% ethanol at 80° C. for 1 h;
  • Step 7 filtration allowing the recovery of marc 3 and extract Z;
  • Step 8 collection of extracts X, Y and Z;
  • Step 9 evaporation of the ethanol and concentration of the extract under vacuum
  • Step 11 filtration, and
  • Step 12 conditioning of the Dendrobium fimbriatum extract.
  • the extract thus obtained bears the INCI name: WATER/AQUA, PROPANEDIOL DENDROBIUM FIMBRIATUM OCULATUM EXTRACT. Its dry matter content is 1%, it includes 35% propanediol and 64% water.
  • EXAMPLE 2 Phytochemical characterization of the extract of Dendrobium fimbriatum prepared according to Example 1.
  • the dry extract dissolved beforehand in a stationary phase/mobile phase mixture, is injected in CPC into a previously equilibrated column (FCPE300® (Rousselet Robatel Kromaton)).
  • FCPE300® Rocket Robatel Kromaton
  • the flow rate was 20 mL/min and the column rotation speed was 1200 rpm.
  • the three-phase solvent system corresponds to n-heptane/methyl-ter-butyl-ether/acetonitrile/water (l/l/l/l, v/v), the separation is carried out in ascending mode.
  • the dry extract dissolved beforehand in a stationary phase/mobile phase mixture, is injected in CPC into a previously balanced column (FCPE300® (Rousselet Robatel Kromaton)).
  • FCPE300® Rocket Robatel Kromaton
  • the flow rate was 20 mL/min and the column rotation speed was 1200 rpm.
  • the three-phase solvent system corresponds to n-heptane/methyl-ter-butyl-ether/acetonitrile/water (l/l/l/l, v/v), the separation is carried out in ascending mode.
  • each 13C NMR chemical shift cluster obtained by HCA was manually submitted to the structure search engine of the ACD/NMR Workbook Suite 2012 database management software (ACD/Labs, Ontario, Canada). understanding the structures and predicted chemical shifts of low molecular weight natural products. 2D NMR experiments (HSQC,
  • HMBC and COZY were carried out on fractions containing supposedly identified compounds in order to confirm the molecular structures proposed by the database at the end of the dereplication process.
  • the crude extract was fractionated by the CPC technique into a total of 13 fractions during two successive experiments.
  • the less polar fractions F1-F4 (representing approximately 3.8% of the mass of the crude extract) were composed of long alkyl chains (fatty acids or alcohols).
  • the moderately polar F5-F10 fractions (representing about 21.6% of the mass of the crude extract) contained a variety of polyphenols (melilotic acid, dendrophenol, dihydromelilotoside), as well as coumarin, syringaldehyde and several phenolic acids such as ortho-coumaric acid, vanillic acid, p-hydroxybenzoic acid and 3-hydroxy-3-(2-hydroxyphenyl)-propanoic acid.
  • EXAMPLE 3 Effect of Dendrobium fimbriatum on the expression of dermal extracellular matrix markers in Normal Human Fibroblasts
  • Normal Human Fibroblasts are derived from an abdominoplasty from a 37-year-old female donor. The cells were seeded in DMEM 1 g/L glucose medium supplemented with 10% fetal calf serum at passage 5 (P5) with a seeding density of 15,000 cells per well, in 96-well plates.
  • the dry extract of Dendrobium fimbriatum was used at a concentration of 50 ug/ml in ethanol
  • the cells were rinsed three times with PBS (PBS Tablets, Invitrogen GIBCO), then fixed with formalin (Formalin Solution 10% Neutral Buffered, Sigma) for 10 minutes. After 3 rinses with PBS, the membranes of the cells were permeabilized or not (depending on the marker studied) with a solution of PBS Triton 0.1% (Triton X-100, Sigma). Then they were again rinsed 3 times with PBS.
  • PBS PBS Tablets, Invitrogen GIBCO
  • formalin Formin Solution 10% Neutral Buffered, Sigma
  • the cells were covered with a 1% PBS/BSA solution (Albumin, from bovine serum, Sigma), for 30 minutes and at room temperature.
  • PBS/BSA solution Albumin, from bovine serum, Sigma
  • the 1% PBS/BSA solution was then replaced with a primary antibody solution corresponding to each labeled protein (see Table 1) diluted in 1% PBS/BSA. Plates were incubated overnight at 4°C.
  • the cells were then rinsed three times with PBS and covered with a solution of secondary antibody according to the primary antibody to be targeted (see Table 1) and DAPI at 1/1000th (4',6'-diamidino-2- phenylindole, dihydrochloride, Invitrogen Molecular Probes) diluted in PBS/BSA 1%. The plates were kept for one hour in the dark and at room temperature.
  • the secondary antibody solution was then aspirated and the cells rinsed twice with PBS and once with distilled water. PBS was deposited in each well at the rate of ImL. Plates were stored at 4°C in the dark until image acquisition.
  • Table 2 List of primary antibodies and conditions of use
  • the plates were scanned with the ArrayScan XTi from Thermo Cellomics.
  • Alexa Fluor 568 filter XF53_572_15
  • the images were then analyzed using arrayscan system analysis software by the Spot detector bio-application.
  • This program makes it possible to detect the red marking of the targeted protein, corresponding to its expression.
  • the surface of the measurement area is delimited as being the entire surface of the image.
  • the number of cells was determined by counting the nuclei by detecting the blue labeling of DAPI.
  • results can be expressed by:
  • this method made it possible to have a general quantification of the synthesis of the marker studied without taking account of the structure.
  • the Student test is said to be significant if its value is less than 0.05.
  • Dendrobium fimbriatum extract according to the invention is capable of significantly increasing the synthesis of several components of the extracellular matrix of the cutaneous environment.
  • This extract is therefore of cosmetic interest for use in connection with the physiological functions of the skin, in particular preventing and/or preventing the loss of firmness, the loss of elasticity of the skin, the reduction in the thickness of the skin, and /or the appearance of wrinkles and/or fine lines.
  • Fibroblasts from the dermis of a donor were cultured and aged through a series of passages that gave them an aged phenotype (senescent fibroblast model).
  • Some morphological markers of senescence were measured by flow cytometry. This technique advantageously makes it possible to study at very high speed and in a quantitative manner the optical characteristics (fluorescence, light scattering linked to cell morphology, etc.) of a large number of cells (several tens of thousands). It is therefore possible to derive statistically significant data.
  • the cells to be studied were suspended in a medium. In the cytometer, the cells are sent one by one into an analysis chamber where they are subjected to several laser beams which make it possible to measure or evaluate cellular parameters. The diffracted light measured in front of the laser beam makes it possible to evaluate the size of the cells (parameter Forward SCatter, FSC).
  • the scattered light measured from the side (Side SCatter SSC parameter) gives a measure of the granularity of the cell.
  • This granularity corresponds to the complexity of the cell, for example the density of organelles, protein aggregates, internal or surface irregularities. With senescence, the size and granularity of cells increase, particularly following oxidative damage to organelles, the accumulation of lipofuscin, or even damage to macromolecules.
  • this extract can be used as an anti-aging active.
  • this composition has remarkable anti-ageing efficacy, in particular to prevent the loss of firmness and elasticity of the skin of the face and neck.
  • this composition provides a firming and smoothing anti-ageing action.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Cosmetics (AREA)
EP21848276.8A 2020-12-18 2021-12-13 Extrait de dendrobium fimbriatum et composition cosmétique non rincée en comprenant Pending EP4262743A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2013687A FR3117870B1 (fr) 2020-12-18 2020-12-18 Extrait deDendrobium fimbriatum et composition cosmétique non rincée en comprenant
PCT/FR2021/052301 WO2022129763A1 (fr) 2020-12-18 2021-12-13 Extrait de dendrobium fimbriatum et composition cosmétique non rincée en comprenant

Publications (1)

Publication Number Publication Date
EP4262743A1 true EP4262743A1 (fr) 2023-10-25

Family

ID=75690331

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21848276.8A Pending EP4262743A1 (fr) 2020-12-18 2021-12-13 Extrait de dendrobium fimbriatum et composition cosmétique non rincée en comprenant

Country Status (6)

Country Link
US (1) US20240099960A1 (ja)
EP (1) EP4262743A1 (ja)
JP (1) JP2023554439A (ja)
CN (1) CN116685306A (ja)
FR (1) FR3117870B1 (ja)
WO (1) WO2022129763A1 (ja)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002205933A (ja) * 2001-01-05 2002-07-23 Ichimaru Pharcos Co Ltd ラン科植物抽出物含有化粧料組成物
CN105617020B (zh) * 2015-12-30 2019-09-27 南京中医药大学 具有皮肤保湿作用的中药组合物及其制备方法与应用
CN105998723A (zh) * 2016-05-10 2016-10-12 南京医科大学友谊整形外科医院有限责任公司 一种具有抗皮肤光老化作用的中药复方
KR102126469B1 (ko) * 2017-09-04 2020-06-24 주식회사 엘지생활건강 철피석곡 꽃 추출물을 포함하는 화장료 조성물
CN110559394A (zh) * 2018-06-06 2019-12-13 捷通国际有限公司 包含金钗石斛的组合物及其使用方法
CN110354008A (zh) * 2019-04-14 2019-10-22 深圳市盛凯元科技有限公司 调护油及其制备方法

Also Published As

Publication number Publication date
FR3117870B1 (fr) 2023-12-29
FR3117870A1 (fr) 2022-06-24
JP2023554439A (ja) 2023-12-27
US20240099960A1 (en) 2024-03-28
WO2022129763A1 (fr) 2022-06-23
CN116685306A (zh) 2023-09-01

Similar Documents

Publication Publication Date Title
EP2953611B1 (fr) Utilisation d'une composition comprenant un perséose d'avocat dans la protection des cellules souches épidermiques
FR3065172A1 (fr) Preparation cosmetique contenant un extrait de truffe blanche et procede cosmetique associe
EP1559417A1 (fr) Principe actif obtenu a partir de poudre de semences de Medicago sativa
FR2928548A1 (fr) Substances augmentant le seuil d'activation des cellules immunes
WO2007034042A2 (fr) Extrait de vanilla planifolia, son procede d’obtention, et composition cosmetique ou dermatologique le contenant
WO2020126653A1 (fr) Extrait de bois de rosier
EP3917554B1 (fr) Procede d'obtention d'un extrait de feuilles de patchouli et ses utilisations cosmetiques
FR3104416A1 (fr) Extraits de bourgeons de roses
FR3013985A1 (fr) Compositions hydratantes comprenant au moins un extrait de caesalpinia spinosa, avec au moins de la vaseline et de la glycerine
EP4262743A1 (fr) Extrait de dendrobium fimbriatum et composition cosmétique non rincée en comprenant
EP3801778A1 (fr) Utilisation d'un extrait de bixa orellana
WO2021233672A1 (fr) Procede d'obtention d'un extrait de bois de santal, compositions le comprenant et ses utilisations cosmetiques
WO2021116616A1 (fr) Composition cosmétique comprenant des extraits de grenadier et de pivoine
FR3111817A1 (fr) Extrait d’Hibiscus sabdariffa et son utilisation pour améliorer la fonction barrière, et favoriser l’hydratation et la desquamation de la peau
FR3076461A1 (fr) Composition cosmétique de prévention active des signes de l’âge.
FR3036962A1 (fr) Composition cosmetique a base de centella asiatica
WO2019077268A1 (fr) Composition cosmétique de prévention active des signes de l'âge
FR3146596A1 (fr) Procede d’obtention d’un extrait de bois de rose, compositions le comprenant et ses utilisations cosmetiques
FR3061016A1 (fr) Utilisation cosmetique d'un extrait de mitracarpus scaber comme agent anti-age
WO2023111458A2 (fr) Fraction bioactive isolée de roses de la variété evanrat
FR3118422A1 (fr) Extrait fermenté de graines de Longoza
WO2021116573A1 (fr) Composition cosmétique comprenant des extraits de kigélia et d'orchidée
WO2021209593A1 (fr) Principe actif comprenant un extrait d'écorce de fruit immature de punica granatum et utilisations pour prevenir et/ou lutter contre l'acne
FR3015247A1 (fr) Utilisation du phosphate de tocopherol comme agent hydratant
FR3100983A1 (fr) Bouquet floral anti-âge

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20230622

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)